ixekizumab,upadacitinib,bimekizumab,camrelizumab,secukinumab
novartis,ucb pharmaceuticals,eli lilly,abbvie,Jiangsu
['bimekizumab', ' upa ', 'bemobile', ' ixe ', 'axspa']
burden of disease, treatment, outcomes are all now comparable.... nr-axspa vs r-axspa rx:
nsaids (any)
cmz (tnfa) - sec (il17a) - ixe (il17a) - upa (jak1)
new = bemobile = bimekizumab - il17a/f
#reviewcourse
#acr22 
(pronounced VUH-neet sun-dhoo) Mother. She/Her/Hers. Rheumatologist. Program Director @lluhealth. Tweets are not medical advice. #ACRAmbassador @lluhphysicians